Prognostic Determinants of Presentation and Outcome in Anti-IgLON5 Disease.

Sabater L, Guasp M, Ruiz García R, Naranjo Rondán L, Querol L, Martín-Aguilar L, Llarch P, Balasa M, Lladó A, Painous C, Compta Y, Serafim AB, Montini A, Iranzo A, Santamaria Cano J, Dalmau JO, Graus F, Gaig C, Anti-IgLON5 Disease Study Group

Open source

DOI: 10.1212/nxi.0000000000200600
Published: 2026 Jul
Container: Neurology(R) neuroimmunology & neuroinflammation
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1212/nxi.0000000000200600,
  title = {Prognostic Determinants of Presentation and Outcome in Anti-IgLON5 Disease.},
  author = {Sabater L and Guasp M and Ruiz García R and Naranjo Rondán L and Querol L and Martín-Aguilar L and Llarch P and Balasa M and Lladó A and Painous C and Compta Y and Serafim AB and Montini A and Iranzo A and Santamaria Cano J and Dalmau JO and Graus F and Gaig C and Anti-IgLON5 Disease Study Group},
  year = {2026},
  journal = {Neurology(R) neuroimmunology \& neuroinflammation},
  doi = {10.1212/nxi.0000000000200600},
  url = {https://doi.org/10.1212/nxi.0000000000200600}
}

RIS

TY  - JOUR
TI  - Prognostic Determinants of Presentation and Outcome in Anti-IgLON5 Disease.
AU  - Sabater L
AU  - Guasp M
AU  - Ruiz García R
AU  - Naranjo Rondán L
AU  - Querol L
AU  - Martín-Aguilar L
AU  - Llarch P
AU  - Balasa M
AU  - Lladó A
AU  - Painous C
AU  - Compta Y
AU  - Serafim AB
AU  - Montini A
AU  - Iranzo A
AU  - Santamaria Cano J
AU  - Dalmau JO
AU  - Graus F
AU  - Gaig C
AU  - Anti-IgLON5 Disease Study Group
PY  - 2026
JO  - Neurology(R) neuroimmunology & neuroinflammation
DO  - 10.1212/nxi.0000000000200600
UR  - https://doi.org/10.1212/nxi.0000000000200600
ER  -

APA

L, S., M, G., R, R. G., L, N. R., L, Q., L, M., P, L., M, B., A, L., C, P., Y, C., AB, S., A, M., A, I., J, S. C., JO, D., F, G., C, G., & Group, A. D. S. (2026). Prognostic Determinants of Presentation and Outcome in Anti-IgLON5 Disease.. Neurology(R) neuroimmunology & neuroinflammation. https://doi.org/10.1212/nxi.0000000000200600

Source records

pubmed · retrieved 2026-09-26T09:29:37.820Z